Delivery Order SPE2DB22D1106-SPE2DB24FFLW7
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a not-to-exceed value of $8,575.68. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which is valued up to $999,999,999 through December 2025 for a wide range...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 with a ceiling value of $2,975.12. The contract is a Firm Fixed Price Delivery Order with a performance period ending on December 11, 2024. The contract does not have a set-aside...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,007.09, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 29, 2024. The contract is not associated with a set-aside designation, indicating open...
This federal contract award is for the delivery of 4,564,793,303 units of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded on June 3, 2024 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, for a ceiling value of $6,423.40. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 4, 2024. This award is not associated with...
This federal contract award is for the delivery of 4,566,660,541 units of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 9, 2024, with a completion date of December 10, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $14,004.61. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $37,267.71 and an ultimate completion date of September 12, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that supplies a wide range of essential medical commodities to various government agencies through indefinite delivery contracts (IDCs). This delivery order is part...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $4,129.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. The contract has a period of performance through September 30, 2024 and does not utilize a set-aside. AmerisourceBergen holds a larger indefinite delivery contract (IDC) valued at up to $999,999,999 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 8 mg Ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA) under a Delivery Order worth $8,518.69. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop...
The federal contract award is for the supply of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,136.32 and runs through December 12, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and expiring in November 2026. The IDC...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $32,573.01 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 16, 2024. The contract has an ultimate completion date of September 17, 2024 and is not set aside for any specific business type. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...